Alpine Immune Sciences Inc (NASDAQ:ALPN) People

Alpine Immune Sciences Inc

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
James Flynn
Other companies: Lite Strategy, Inc. (Director · Since at least Oct 31, 2023); Nuvalent, Inc. (Director · Since at least Jul 28, 2021); Larimar Therapeutics, Inc. (Director · Since at least May 28, 2020); Synlogic Inc (Director · Mar 19, 2024 – Apr 26, 2025 · Past); BiomX Inc. (Director · Mar 15, 2024 – Apr 21, 2025 · Past); Oruka Therapeutics, Inc. (Director · Jan 30, 2024 – Jan 30, 2024 · Past); RiceBran Technologies (Director · Jan 3, 2024 – Jan 3, 2024 · Past); CareMax Inc (Director · Nov 17, 2022 – Nov 17, 2023 · Past); ARS Pharmaceuticals, Inc. (Director · Nov 8, 2022 – Nov 8, 2022 · Past); Da32 Life Science Tech Acquisition Corp (Director · Jul 27, 2021 – Jul 28, 2023 · Past); Oncorus Inc (Director · Oct 1, 2020 – Feb 17, 2021 · Past); Acutus Medical Inc. (Director · Aug 5, 2020 – Jan 27, 2025 · Past); Deerfield Healthcare Technology Acquisitions Corp (Director · Jul 16, 2020 – Jul 21, 2020 · Past); Q32 Bio Inc. (Director · Mar 27, 2018 – Jun 6, 2019 · Past); AdaptHealth Corp. (Director · Feb 15, 2018 – Nov 8, 2019 · Past); AveXis Inc (Director · Sep 3, 2015 – Feb 10, 2016 · Past)
Director · Sep 12, 2016 – Sep 12, 2016 · Past
James N Topper
Other companies: Attovia Therapeutics, Inc. (Director · Since at least Aug 4, 2026); NewAmsterdam Pharma Company N.V. (Director · Since at least Dec 29, 2023); Phathom Pharmaceuticals, Inc. (Director · Since at least Oct 24, 2019); Frazier Lifesciences Acquisition Corp (Chief Executive Officer, Director · Dec 8, 2020 – Dec 11, 2020 · Past); Entasis Therapeutics Holdings Inc (Director · Sep 25, 2018 – Jan 18, 2019 · Past); Aptinyx Inc (Director · Jun 20, 2018 – Mar 31, 2020 · Past); Allena Pharmaceuticals Inc (Director · Nov 1, 2017 – Nov 17, 2020 · Past); AnaptysBio, Inc. (Director · Jan 25, 2017 – Jan 6, 2023 · Past); Sierra Oncology Inc (Director · Jul 15, 2015 – Feb 14, 2017 · Past); Portola Pharmaceuticals Inc (Director · May 21, 2013 – Jun 5, 2013 · Past); Amicus Therapeutics Inc (Director · Jun 15, 2010 – Jun 12, 2014 · Past)
Director · Jul 24, 2017 – May 18, 2024 · Past
Cynthia Smith
Other companies: Tvardi Therapeutics, Inc. (Board Member · Since at least Apr 15, 2025); Agios Pharmaceuticals, Inc. (Independent Director · Since at least Aug 11, 2022); Protara Therapeutics, Inc. (Director · Since at least Jan 29, 2021); Spero Therapeutics, Inc. (Director · Since at least Mar 19, 2019); Akebia Therapeutics, Inc. (Senior Vice President, Market Access and Commercial Development · Since at least Aug 28, 2018); Dicerna Pharmaceuticals Inc (Director · Aug 13, 2018 – Dec 28, 2021 · Past); ZS Pharma Inc (Chief Commercial Officer · Jun 17, 2014 – Dec 17, 2015 · Past)
Director · Nov 1, 2016 – Nov 1, 2016 · Past
Paul Sekhri
Other companies: Apnimed, Inc. (Director · Since at least Jul 30, 2026); vTv Therapeutics Inc. (Chairman of the Board, President and Chief Executive Officer · Since at least Aug 1, 2022); Veeva Systems Inc. (Director · Since at least Jun 22, 2016); Axcella Health Inc (Director · May 19, 2022 – May 19, 2022 · Past); Longboard Pharmaceuticals Inc (Director · Mar 11, 2021 – Dec 2, 2024 · Past); BiomX Inc. (Director · Oct 2, 2020 – Jul 28, 2021 · Past); Enumeral Biomedical Holdings Inc (Director · Dec 9, 2016 – Dec 9, 2016 · Past)
Director · Sep 12, 2016 – Jan 2, 2020 · Past
Jonathan Leff
Other companies: Larimar Therapeutics, Inc. (Director · Since at least May 28, 2020); BiomX Inc. (Director · Mar 15, 2024 – Apr 14, 2025 · Past); ARS Pharmaceuticals, Inc. (Director · Nov 8, 2022 – Nov 8, 2022 · Past); Protara Therapeutics, Inc. (Director · Aug 2, 2017 – Jun 8, 2018 · Past); AveXis Inc (Director · Feb 10, 2016 – Feb 10, 2016 · Past); InterMune Inc (EVP, Research & Development · Feb 27, 2012 – Sep 29, 2014 · Past)
Director · Jun 16, 2015 – Sep 11, 2015 · Past
Xiangmin Cui
Other companies: Nuvation Bio Inc. (Director · Since at least Apr 9, 2024); Armo Biosciences Inc. (Director · Jan 25, 2018 – Jun 22, 2018 · Past); China Biologic Products Holdings Inc (Director · Feb 4, 2010 – Jan 1, 2011 · Past)
Director · Jan 18, 2019 – May 18, 2024 · Past
Andrew Sandler M.D.
Other companies: Dermata Therapeutics, Inc. (Director · Since at least Aug 12, 2021); Dendreon Corp (EVP, Chief Medical Officer · Jan 13, 2014 – Feb 13, 2015 · Past)
Chief Medical Officer · Aug 17, 2022 – Jan 5, 2023 · Past
Christopher Peetz
Other companies: Arcutis Biotherapeutics, Inc. (Director · Since at least Jul 15, 2026); Mirum Pharmaceuticals, Inc. (CHIEF EXECUTIVE OFFICER, Director · Since at least Jul 17, 2019)
Director · Apr 20, 2018 – May 20, 2024 · Past
James Paul Rickey
Other companies: Braveheart Bio, Inc. (Chief Financial Officer · Since at least Aug 5, 2026); Immune Design Corp (VP, Finance and Administration · Jul 23, 2014 – Jan 7, 2015 · Past)
See Remarks · Jul 24, 2017 – May 20, 2024 · Past
Jay Venkatesan
Other companies: Serina Therapeutics, Inc. (Director · Since at least Feb 12, 2025); Elicio Therapeutics, Inc. (Director · Since at least May 20, 2022)
Director · Jul 15, 2022 – Jul 15, 2022 · Past
Mark Litton
Other companies: LeonaBio, Inc. (President & CEO · Since at least Sep 17, 2020); Alder BioPharmaceuticals Inc (Chief Business Officer · May 7, 2014 – Jun 1, 2018 · Past)
See Remarks · Aug 6, 2018 – Feb 6, 2019 · Past
David Malcom Rodman
Other companies: Mineralys Therapeutics, Inc. (Chief Medical Officer · Since at least Feb 9, 2023)
Exec Vice President and CMO · Apr 18, 2016 – Jan 3, 2017 · Past
John Moore
Other companies: Edgewise Therapeutics, Inc. (General Counsel · Since at least Mar 25, 2021)
Director · Jun 16, 2015 – Sep 12, 2016 · Past
Robert E Conway
Other companies: Oruka Therapeutics, Inc. (Director · Sep 3, 2013 – Jan 30, 2024 · Past)
Director · Jun 16, 2015 – May 20, 2024 · Past
Janice TrohaExec Vice President / COO · Jun 16, 2015 – May 5, 2017 · Past
Remy DurandChief Business Officer · Apr 21, 2023 – May 20, 2024 · Past
Steven ShoemakerVP Clinical R&D · Jun 16, 2015 – Sep 11, 2015 · Past
Ulrich Martin FuhsChief Accounting Officer · Apr 3, 2024 – May 20, 2024 · Past